HIV patients successfully switch from shots to daily pill in new study

NCT ID NCT06104306

Completed Disease control Sponsor: Gilead Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 33 adults with well-controlled HIV who switched from a monthly injectable treatment (CAB+RPV) to a daily oral pill (B/F/TAF). The main goal was to check if the switch was safe, especially for those who couldn't or didn't want to continue injections. Over 12 weeks, researchers monitored for serious side effects and lab changes. The study found that switching to the oral pill was a safe option for these patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV-1-INFECTION

Contacts and locations

Locations

APHM - Hospital Sainte Marguerite

Marseille, France
BIOS Clinical Research

Palm Springs, California, 92262, United States
Bliss Health

Orlando, Florida, 32806, United States
Boston Medical Center

Boston, Massachusetts, 02118, United States
CHR Orleans

Orléans, 45100, France
CHU Bordeaux - Hopital Saint-Andre

Bordeaux, 33075, France
Centre Hospitalier Annecy Genevois

Pringy, 74374, France
Franco Felizarta, MD

Bakersfield, California, 93301, United States
HU de Strasbourg - Nouvel Hopital Civil

Strasbourg, France
Hamilton Health Sciences-SIS Clinic

Hamilton, L8L2X2, Canada
Indiana University Infectious Diseases Research

Indianapolis, Indiana, 46202, United States
Las Vegas Research Center

Las Vegas, Nevada, 89106, United States
Midway Immunology and Research Center

Ft. Pierce, Florida, 34982, United States
MultiCare Rockwood Main Clinic

Spokane, Washington, 99202, United States
Saint Michael's Medical Center

Newark, New Jersey, 07102, United States
St. Michael's Hospital

Toronto, M5B 1W8, Canada
UC San Diego AntiViral Research Center (AVRC)

San Diego, California, 92103, United States
University Health Network - Toronto General Hospital

Toronto, M5G 2C4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.